We are live on ! Find out more
FA

Faithward Advisors Portfolio holdings

AUM $819M
1-Year Est. Return 41.44%
This Fund
S&P 500
This Quarter Est. Return
+20.05%
1 Year Est. Return
+41.44%
3 Year Est. Return
+118.63%
5 Year Est. Return
+111.84%
10 Year Est. Return
AUM
$819M
AUM Growth
+$119M
Cap. Flow
-$6.31M
Cap. Flow %
-0.77%
Top 10 Hldgs %
25.82%
Holding
354
New
93
Increased
93
Reduced
145
Closed
15

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.2M
2
AVGO icon
Broadcom
AVGO
+$12.9M
3
KLAC icon
KLA
KLAC
+$11.2M
4
AMKR icon
Amkor Technology
AMKR
+$9.05M
5
UI icon
Ubiquiti
UI
+$5.95M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$44.9M
2
ITW icon
Illinois Tool Works
ITW
+$21.2M
3
TTE icon
TotalEnergies
TTE
+$18.8M
4
APH icon
Amphenol
APH
+$15M
5
CRWD icon
CrowdStrike
CRWD
+$9.05M

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.71%
2 Technology 20.16%
3 Industrials 9.81%
4 Financials 6.37%
5 Healthcare 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
351
Pfizer
PFE
$162B
-7,434
Closed -$209K
TEL icon
352
TE Connectivity
TEL
$60.4B
-1,185
Closed -$248K
WBD icon
353
Warner Bros
WBD
$70.8B
-7,772
Closed -$213K
ZTS icon
354
Zoetis
ZTS
$31.3B
-1,793
Closed -$212K

Similar funds

Faithward Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Faithward Advisors held 354 positions worth $819M, up 17% from $701M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Faithward Advisors's Q2 2026 filing shows 93 new, 93 increased, 145 reduced and 15 closed positions. Its largest new stake was Apple: 46,051 shares worth $13.3M. The largest sale was Amgen, an estimated $44.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 49% a quarter earlier, followed by Technology and Industrials.

  • Faithward Advisors's largest Q2 2026 buy was Apple: 46,051 shares worth $13.3M.
  • Faithward Advisors added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $5.85M increase.
  • Faithward Advisors's biggest Q2 2026 reduction was Amgen, cutting an estimated $44.9M.
  • Faithward Advisors fully exited Charles River Laboratories in Q2 2026, selling an estimated $1.27M.
  • Faithward Advisors's ten largest holdings make up 26% of its $819M portfolio in Q2 2026.
  • Faithward Advisors opened 93 new positions and closed 15 in Q2 2026.
  • Faithward Advisors's portfolio value rose 17% quarter-over-quarter to $819M.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.